Altre lingue Aeterna Zentaris Inc. Nasdaq

Azioni

AEZS

CA0079756007

Mercato chiuso - Nasdaq Altri mercati azionari 22:30:00 07/05/2024			Variaz. 5gg	Var. 1 gen.
8,03 ^USD	+0,50%		+2,95%	+7,93%

27/03	Aeterna Zentaris riporta una perdita netta nel quarto trimestre di 5,6 milioni di dollari, e fornisce un aggiornamento sulla sperimentazione DETECT	MT
27/03	Aeterna Zentaris Inc. riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Aeterna Zentaris Announces Effective Date of Share Consolidation	01/05
North American Morning Briefing : Powell Awaited -2-	03/04
Ceapro Brief: Parties anticipate completing Transaction in Q2 2024, subject to obtaining all required approvals and satisfying all required conditions	28/03
Ceapro Brief: Says Received Final Court Approval for Merger with Aeterna Zentaris	28/03
Aeterna Zentaris Reports Q4 Net Loss of US$5.6 Million, Provides DETECT Trial Update	27/03
Aeterna Zentaris Brief: Announcing Completion of Enrollment in Ongoing Pivotal DETECT-Trial for Diagnosis of Childhood-Onset Growth Hormone Deficiency	27/03
Aeterna Zentaris Brief: Reporting Q4 Net Loss of US$5.6 million, or $1.16 loss per common share	27/03
Aeterna Zentaris Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	27/03
Aeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completion of Enrollment in Ongoing Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency	27/03
Aeterna Zentaris : Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completion of Enrollment in Ongoing Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency - Form 6-K	27/03
Aeterna Zentaris : Consolidated Financial Statements As of December 31, 2023 and 2022 and for the years ended December 31, 2023, 2022 and 2021 - Form 6-K	27/03
North American Morning Briefing : Stocks Edge -2-	27/03
North American Morning Briefing : Markets on Hold -2-	20/03
Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings	12/03
Ceapro Brief: Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR Arrangement Agreement to Approve Merger of Equals to Create a Diversified Biopharmaceutical Co	26/02
Aeterna Zentaris Issues Letter to Shareholders and Management Proxy Circular Ahead of Special Meeting of Shareholders to Approve Merger of Equals with Ceapro	15/02
Traders Search for Fresh Cues After Fed-Driven Rally as US Equity Futures Waver Pre-Bell	18/12
Top Premarket Gainers	18/12
AEZS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Aeterna Zentaris Inc. Is Fair to Shareholders	14/12
Aeterna Zentaris and Ceapro Announce Merger of Equals to Create Diversified Biopharmaceutical Co	14/12

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Aeterna Zentaris Inc. Nasdaq

Azioni

AEZS

CA0079756007

Altre lingue

Filtri